(1-177) Medication Use Evaluation: Evaluation of Sodium–Glucose Cotransporter-2 (SGLT2) Inhibitor-induced Erythrocytosis

Sunday, December 7, 2025

3:30 PM - 5:00 PM

Location: Bayside A, Level 1

Federal Agency: Department of Veterans Affairs

Co-Author(s): Sarah E. Nieberding

Primary Author(s)

Ann E. Weyand, PharmD

PGY2 Ambulatory Care Pharmacy Resident
Lebanon VA Medical Center